1/31/2019 9:04:25 AM
Prana Gets First Orphan Drug Designation From FDA For Treatment Of Multiple System Atrophy
6/13/2018 9:10:01 PM
Prana To Commence Phase 1 Trial Of PBT434 For Treatment Of Parkinsonian Diseases
1/5/2018 1:20:37 PM
B. Riley FBR Starts Prana Biotechnology Ltd (PRAN) At Buy With $4.00 Price Target